Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways.

about

MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.Locomotor differences in mice expressing wild-type human α-synuclein.

P2860

Q37702119-0FDC081C-BDA0-4D29-926B-F8BF23240CA1 Q51767457-9B9C15FE-CBB8-4037-8061-75BC027A2470

P2860

Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways.

Item

http://www.wikidata.org/entity/Q48565252

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Mutant A53T α-Synuclein Improv ...... nd Affects Metabolic Pathways.

@en

Mutant A53T α-Synuclein Improv ...... nd Affects Metabolic Pathways.

@nl

type

Item

label

Mutant A53T α-Synuclein Improv ...... nd Affects Metabolic Pathways.

@en

Mutant A53T α-Synuclein Improv ...... nd Affects Metabolic Pathways.

@nl

prefLabel

Mutant A53T α-Synuclein Improv ...... nd Affects Metabolic Pathways.

@en

Mutant A53T α-Synuclein Improv ...... nd Affects Metabolic Pathways.

@nl

P1476

Mutant A53T α-Synuclein Improv ...... nd Affects Metabolic Pathways.

@en

P2093

Teresa F Pais

http://www.w3.org/2001/XMLSchema#string

P2860

alpha-Synuclein locus triplication causes Parkinson's disease

The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS

The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia

Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease

Alpha-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of alpha-synuclein palmitate binding

Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.

Tests to assess motor phenotype in mice: a user's guide.

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

P2888

s12017-016-8435-5

P304

113-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12017-016-8435-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M P. Macedo

Joana E. Coelho

Luísa V. Lopes

Patrícia S. Guerreiro

Inês S Lima

Tiago Fleming Outeiro

P577

2016-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27535567

http://www.w3.org/2001/XMLSchema#string

P921

Synuclein

Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways.

about

P2860

P2860

Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921